Enfusion, Inc. (NYSE:ENFN - Get Free Report) COO Neal Pawar sold 21,801 shares of the business's stock in a transaction dated Monday, December 2nd. The stock was sold at an average price of $10.03, for a total value of $218,664.03. Following the transaction, the chief operating officer now directly owns 1,143,544 shares of the company's stock, valued at $11,469,746.32. This represents a 1.87 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink.
Enfusion Stock Performance
NYSE ENFN opened at $10.11 on Thursday. Enfusion, Inc. has a twelve month low of $7.52 and a twelve month high of $10.40. The stock has a market capitalization of $1.30 billion, a PE ratio of 252.81, a P/E/G ratio of 3.79 and a beta of 0.97. The stock has a 50-day simple moving average of $9.36 and a 200 day simple moving average of $8.90.
Hedge Funds Weigh In On Enfusion
Large investors have recently made changes to their positions in the business. RiverPark Advisors LLC bought a new stake in Enfusion in the 2nd quarter valued at $68,000. Arizona State Retirement System acquired a new position in shares of Enfusion in the 2nd quarter valued at $86,000. Price T Rowe Associates Inc. MD acquired a new position in shares of Enfusion in the 1st quarter valued at $102,000. Harbor Capital Advisors Inc. raised its stake in shares of Enfusion by 12.4% in the 3rd quarter. Harbor Capital Advisors Inc. now owns 11,887 shares of the company's stock valued at $113,000 after buying an additional 1,315 shares in the last quarter. Finally, Belvedere Trading LLC acquired a new position in shares of Enfusion in the 3rd quarter valued at $114,000. Institutional investors and hedge funds own 81.05% of the company's stock.
About Enfusion
(
Get Free Report)
Is Starlink Set For The Largest IPO In History?
From Paradigm Press | Ad
He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant.
Then, he did it again with Tesla… which is up more than 19,500% since 2010.
For perspective, that turns $100 invested into almost $20,000!
Click here now for the urgent details.
Enfusion, Inc provides software-as-a-service solutions for investment management industry in the United States, Europe, the Middle East, Africa, and the Asia Pacific. The company provides Portfolio Management System, which generates a real-time investment book of record that consists of valuation and risk tools, which allows users to analyze aggregated or decomposed portfolio data for chief investment officers (CIOs) and portfolio managers; and Order and Execution Management System that enables portfolio managers, traders, compliance teams, and analysts to electronically communicate trade orders for a variety of asset classes, manage trade orders, and systemically enforce trading regulations and internal guidelines.
See Also
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. This story was reviewed by InsiderTrades.com's editorial team prior to publication. Please send any questions or comments about this story to [email protected].
